ALPS Advisors’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$670K Sell
41,256
-352
-0.8% -$6.23K ﹤0.01% 653
2025
Q4
$778K Buy
41,608
+17,394
+72% +$289K ﹤0.01% 633
2025
Q3
$354K Sell
24,214
-2,793
-10% -$35.3K ﹤0.01% 934
2025
Q2
$298K Sell
27,007
-9,072
-25% -$88.2K ﹤0.01% 936
2025
Q1
$322K Sell
36,079
-3,680
-9% -$34.2K ﹤0.01% 880
2024
Q4
$374K Buy
39,759
+2,323
+6% +$21.1K ﹤0.01% 737
2024
Q3
$302K Sell
37,436
-508
-1% -$4.4K ﹤0.01% 956
2024
Q2
$322K Buy
+37,944
New +$342K ﹤0.01% 814
2018
Q4
Sell
-97,513
Closed -$3.19M 937
2018
Q3
$3.19M Buy
97,513
+17,906
+22% +$488K 0.02% 198
2018
Q2
$1.8M Buy
79,607
+7,043
+10% +$167K 0.01% 239
2018
Q1
$1.76M Buy
72,564
+12,613
+21% +$346K 0.01% 221
2017
Q4
$1.67M Buy
59,951
+6,938
+13% +$205K 0.01% 206
2017
Q3
$1.81M Buy
53,013
+4,944
+10% +$162K 0.01% 196
2017
Q2
$1.92M Buy
+48,069
New +$1.85M 0.01% 186
2015
Q2
Sell
-15,967
Closed -$277K 689
2015
Q1
$277K Buy
+15,967
New +$293K ﹤0.01% 627

Other funds holding TBPH